Drexel University:製薬・医療:M&Aディール及び事業提携情報

◆英語タイトル:Drexel University - Pharmaceuticals & Healthcare - Deals and Alliances Profile
◆商品コード:DATA904C12408
◆発行会社(調査会社):GlobalData
◆発行日:2018年12月
◆ページ数:27
◆レポート言語:英語
◆レポート形式:PDF
◆納品方法:Eメール
◆対象地域:アメリカ
◆産業分野:製薬・医療
◆販売価格オプション(消費税別)
Single User(1名様閲覧用)USD250 ⇒換算¥37,000見積依頼/購入/質問フォーム
Site License(同一事業所内共有可)USD500 ⇒換算¥74,000見積依頼/購入/質問フォーム
Enterprisewide License(複数事業所内共有可)USD750 ⇒換算¥111,000見積依頼/購入/質問フォーム
販売価格オプションの説明はこちらでご利用ガイドはこちらでご確認いただけます。
※お支払金額は「換算金額(日本円)+消費税+配送料(Eメール納品は無料)」です。
※本体価格が¥30,000未満のレポートにつきましては、ハンドリングチャージ¥5,000が別途かかります。
※Eメールによる納品の場合、通常ご注文当日〜2日以内に納品致します。
※レポート納品後、納品日+5日以内に請求書を発行し、お客様宛に郵送しますので、請求書発行日より2ヶ月以内に振込をお願いします。
※為替レートは適宜修正・更新しております。リアルタイム更新ではありません。
※弊社H&Iグローバルリサーチ株式会社はGlobalData社の日本における正規販売代理店です。同社発行の企業調査レポートに関するお問い合わせは弊社までお願い致します。
GlobalData社の概要はこちらでご確認いただけます。



【レポートの概要】

Summary
Drexel University (Drexel) is a research university which provides educational degrees and research programs. The university offers courses for undergraduate courses, graduate and professional courses, adult education programs, colleges and schools, libraries and online training services. It also provides professional degree programs in architecture, science, chemical engineering, civil engineering, construction management, culinary science, nutrition and food, information systems and sports management. Drexel University also conducts research programs. The university operates through its campuses in various cities throughout the US. Drexel is headquartered in Philadelphia, Pennsylvania, the US.

Drexel University – Pharmaceuticals & Healthcare – Deals and Alliances Profile provides you comprehensive data and trend analysis of the company’s Mergers and Acquisitions (M&As), partnerships and financings. The report provides detailed information on Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnership transactions recorded by the company over a five year period. The report offers detailed comparative data on the number of deals and their value categorized into deal types, sub-sector and regions.

GlobalData derived the data presented in this report from proprietary in-house Pharma eTrack deals database, and primary and secondary research.

Scope

- Financial Deals – Analysis of the company’s financial deals including Mergers and Acquisitions, Equity/Debt Offerings, Private Equity, Venture Financing and Partnerships.
- Deals by Year – Chart and table displaying information encompassing the number of deals and value reported by the company by year, for a five year period.
- Deals by Type – Chart and table depicting information including the number of deals and value reported by the company by type such as Mergers and Acquisitions, Equity/Debt Offering etc.
- Deals by Region – Chart and table presenting information on the number of deals and value reported by the company by region, which includes North America, Europe, Asia Pacific, the Middle East and Africa and South and Central America.
- Deals by Sub-sector – Chart and table showing information on the number of deals and value reported by the company, by sub-sector.
- Major Deals – Information on the company’s major financial deals. Each such deal has a brief summary, deal type, deal rationale; and deal financials and target Company’s (major public companies) key financial metrics and ratios.
- Business Description – A brief description of the company’s operations.
- Key Employees – A list of the key executives of the company.
- Important Locations and Subsidiaries – A list and contact details of key centers of operation and subsidiaries of the company.
- Key Competitors – A list of the key competitors of the company.
- Key Recent Developments – A brief on recent news about the company.

Reasons to Buy

Get detailed information on the company’s financial deals that enable you to understand the company’s expansion/divestiture and fund requirements
- The profile enables you to analyze the company’s financial deals by region, by year, by business segments and by type, for a five year period.

Understand the company’s business segments’ expansion / divestiture strategy
- The profile presents deals from the company’s core business segments’ perspective to help you understand its corporate strategy.

Access elaborate information on the company’s recent financial deals that enable you to understand the key deals which have shaped the company
- Detailed information on major recent deals includes a summary of each deal, deal type, deal rationale, deal financials and Target Company’s key financial metrics and ratios.

Equip yourself with detailed information about the company’s operations to identify potential customers and suppliers.
- The profile analyzes the company’s business structure, locations and subsidiaries, key executives and key competitors.

Stay up-to-date on the major developments affecting the company
- Recent developments concerning the company presented in the profile help you track important events.

Gain key insights into the company for academic or business research
- Key elements such as break up of deals into categories and information on detailed major deals are incorporated into the profile to assist your academic or business research needs.

Note*: Some sections may be missing if data is unavailable for the company.

【レポートの目次】

Table of Contents
Table of Contents 3
List of Tables 4
List of Figures 4
Drexel University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Drexel University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Drexel University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Drexel University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8
Drexel University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
Drexel University, Pharmaceuticals & Healthcare, Deal Details 10
Partnerships 10
CytoDyn Amends Research Agreement with Drexel University College of Medicine 10
Licensing Agreements 11
Oncore Biopharma Enters into Licensing Agreement with Baruch S. Blumberg Institute and Drexel University 11
Oncore Biopharma Enters into Licensing Agreement with Baruch S. Blumberg Institute and Drexel University 12
OnCore Biopharma Enters into Licensing Agreement with Drexel University 13
Drexel University – Key Competitors 14
Drexel University – Key Employees 15
Drexel University – Locations And Subsidiaries 16
Head Office 16
Other Locations & Subsidiaries 16
Recent Developments 17
Strategy And Business Planning 17
Apr 16, 2018: Geisinger expands access to clinical trials through consortium with five other health systems 17
Government and Public Interest 19
Jun 21, 2018: Medicaid Expansion Under the ACA Increased Low-Income Patient Access to Kidney Transplants 19
Apr 16, 2018: Drexel Joins Regional Health Systems to Expand Access to Clinical Trials 21
Apr 16, 2018: Six Health Systems form Consortium to Expand Access to Clinical Trials, Bringing Access to Clinical Trials Closer to Home 22
Oct 05, 2017: Multivitamin Use During Pregnancy Linked to Lower Risk of Autism With Intellectual Disability 23
Sep 07, 2017: NIH awards nearly $100 million for Autism Centers of Excellence program 24
Jun 06, 2017: Study Identifies an Enzyme Inhibitor to Treat Gulf War Illness Symptoms 26
Appendix 27
Methodology 27
About GlobalData 27
Contact Us 27
Disclaimer 27

List of Tables
Drexel University, Pharmaceuticals & Healthcare, Key Facts 2
Drexel University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Drexel University, Pharmaceuticals & Healthcare Deals By Type, 2012 to YTD 2018 6
Drexel University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Drexel University, Deals By Therapy Area, 2012 to YTD 2018 8
Drexel University, Pharmaceuticals & Healthcare, Deals Summary, 2012 to YTD 2018 9
CytoDyn Amends Research Agreement with Drexel University College of Medicine 10
Oncore Biopharma Enters into Licensing Agreement with Baruch S. Blumberg Institute and Drexel University 11
Oncore Biopharma Enters into Licensing Agreement with Baruch S. Blumberg Institute and Drexel University 12
OnCore Biopharma Enters into Licensing Agreement with Drexel University 13
Drexel University, Key Competitors 14
Drexel University, Key Employees 15
Drexel University, Other Locations 16
Drexel University, Subsidiaries 16

List of Figures
Drexel University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 2
Drexel University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 2
Drexel University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 2
Drexel University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 2
Drexel University, Pharmaceuticals & Healthcare, Deals By Year, 2012 to YTD 2018 5
Drexel University, Pharmaceuticals & Healthcare, Deals by Type, 2012 to YTD 2018 6
Drexel University, Pharmaceuticals & Healthcare, Deals By Region, 2012 to YTD 2018 7
Drexel University, Pharmaceuticals & Healthcare, Deals By Therapy Area, 2012 to YTD 2018 8

★海外企業調査レポート[Drexel University:製薬・医療:M&Aディール及び事業提携情報]についてメールでお問い合わせはこちら

■おすすめ企業レポート■
  • MTY Food Group Inc.:戦略・SWOT・企業財務分析
    MTY Food Group Inc. - Strategy, SWOT and Corporate Finance Report Summary MTY Food Group Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Teva Pharmaceutical Industries Ltd (TEVA):医療機器:M&Aディール及び事業提携情報
    Summary Teva Pharmaceutical Industries Ltd (Teva) is a pharmaceutical company that carries out the research, development, manufacture and commercialization of generic and specialty medicines. It provides specialty medicines to treat disorders of the central nervous system (CNS), respiratory, cancer, …
  • Akcea Therapeutics Inc (AKCA):製薬・医療:M&Aディール及び事業提携情報
    Summary Akcea Therapeutics Inc (Akcea Therapeutics), a subsidiary of Ionis Pharmaceuticals Inc, is a developer and commercializer of drugs to treat patients with cardiometabolic diseases caused by lipid disorders. The company’s drugs are designed based on advanced antisense technology. Its pipeline …
  • Cherkizovo Group OJSC (GCHE):企業の財務・戦略的SWOT分析
    Cherkizovo Group OJSC (GCHE) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknes …
  • Intrum Justitia AB:企業のM&A・事業提携・投資動向
    Intrum Justitia AB - Mergers & Acquisitions (M&A), Partnerships & Alliances and Investment Report Summary Marketline's Intrum Justitia AB Mergers & Acquisitions (M&A), Partnerships & Alliances and Investments report includes business description, detailed reports on mergers and acquisitions (M&A), d …
  • Sigdo Koppers SA:企業の戦略・SWOT・財務情報
    Sigdo Koppers SA - Strategy, SWOT and Corporate Finance Report Summary Sigdo Koppers SA - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings and cor …
  • Nu Skin Enterprises, Inc.:企業の戦略・SWOT・財務情報
    Nu Skin Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report Summary Nu Skin Enterprises, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service …
  • Koninklijke Ahold Delhaize N.V.:戦略・SWOT・企業財務分析
    Koninklijke Ahold Delhaize N.V. - Strategy, SWOT and Corporate Finance Report Summary Koninklijke Ahold Delhaize N.V. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product …
  • Ascend Therapeutics US LLC:製薬・医療:M&Aディール及び事業提携情報
    Summary Ascend Therapeutics US LLC (Ascend Therapeutics), a subsidiary of Besins Healthcare SA, is a pharmaceutical company that offers women’s healthcare products. The company discovers, develops and markets transdermal drug delivery products. Its product includes estrogel, a non patch transdermal …
  • Titan Machinery Inc (TITN):企業の財務・戦略的SWOT分析
    Titan Machinery Inc (TITN) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesse …
  • Adverum Biotechnologies Inc (ADVM):企業の財務・戦略的SWOT分析
    Summary Adverum Biotechnologies Inc (Adverum), formerly Avalanche Biotechnologies Inc, is a clinical-stage gene therapy provider. The company’s product pipeline includes AVDM-053, ADVM-022 and AVA-311. Its products are used for treatment of antitrypsin deficiency, hereditary angioedema, wet age-rela …
  • Hudson Global Inc (HSON):企業の財務・戦略的SWOT分析
    Hudson Global Inc (HSON) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weaknesses …
  • AIMM Therapeutics BV-製薬・医療分野:企業M&A・提携分析
    Summary AIMM Therapeutics BV (AIMM Therapeutics) is a biotechnology company that develops progressive approach to the discovery of therapeutic antibodies for the treatment of cancer and infectious diseases. The company offers research programs for prevention and treatment of diseases with medical ne …
  • Swietelsky Baugesellschaft mbH:企業の戦略的SWOT分析
    Swietelsky Baugesellschaft mbH - Strategic SWOT Analysis Review provides a comprehensive insight into the company’s history, corporate strategy, business structure and operations. The report contains a detailed SWOT analysis, information on the company’s key employees, key competitors and major prod …
  • Invuity Inc (IVTY):企業の財務・戦略的SWOT分析
    Summary Invuity Inc (Invuity) is a medical technology company that develops and markets advanced surgical devices for the minimally invasive and minimal access procedures. The company offers illuminated surgical retractors, single-use handheld aspiration and universal drop-in intracavity illuminator …
  • Beckman Coulter, Inc.:企業の戦略・SWOT・財務情報
    Beckman Coulter, Inc. - Strategy, SWOT and Corporate Finance Report Summary Beckman Coulter, Inc. - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerin …
  • Karoon Gas Australia Ltd (KAR):企業の財務・戦略的SWOT分析
    Karoon Gas Australia Ltd (KAR) - Financial and Strategic SWOT Analysis Review provides you an in-depth strategic SWOT analysis of the company’s businesses and operations. The profile has been compiled by GlobalData to bring to you a clear and an unbiased view of the company’s key strengths and weakn …
  • Baldwin & Lyons Inc:企業の戦略・SWOT・財務情報
    Baldwin & Lyons Inc - Strategy, SWOT and Corporate Finance Report Summary Baldwin & Lyons Inc - Strategy, SWOT and Corporate Finance Report, is a source of comprehensive company data and information. The report covers the company's structure, operation, SWOT analysis, product and service offerings a …
  • Boston Children’s Hospital:医療機器:M&Aディール及び事業提携情報
    Summary Boston Children's Hospital (Boston Children’s) is the pediatric medical center that provides a comprehensive range of health care services for children from birth through 21 years of age. Boston Children’s is the primary pediatric teaching affiliate of Harvard Medical School. The organizatio …
  • Matinas BioPharma Holdings Inc (MTNB):製薬・医療:M&Aディール及び事業提携情報
    Summary Matinas BioPharma Holdings Inc (Matinas BioPharma) is a clinical-stage biopharmaceutical company that discovers and develops anti-infectives for orphan indications. The company develops lipid nano-crystal (LNC) technology, a drug delivery platform to deliver various molecules such as small m …

◆H&Iグローバルリサーチ株式会社のお客様(例)◆